Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CureGenetics Logo
CureGenetics Growth Score
87
CB Rank
52310
Heat Score
36
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Founded
obfuscation
PrivateSeries B Suzhou, Jiangsu, China51-100 www.curegenetics.com/
Biotechnology
Genetics
Health Care
Overview

CureGenetics
Total Funding
obfuscation
Growth Score
87
Heat Score
36

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score87
-2 pts
in past quarter
Heat Score 36
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CureGenetics

CB Rank
52310
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Founded
obfuscation
PrivateSeries B Suzhou, Jiangsu, China51-100 www.curegenetics.com/
Biotechnology
Genetics
Health Care

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Suzhou Kerui Gene Biotechnology Co., Ltd.
Also Known As Suzhou Kerui Gene Biotechnology, Kregene, 克睿基因, Cree Gene
Operating Status Active
Company Type For Profit
Founders  Yuanyuan Xu
About the Company
Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases.
Contact Email info@curegenetics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AIMS CAR-NKT Platform
A cell therapy platform using invariant natural killer T cells engineered with CAR to target solid tumors, enhancing tumor infiltration and modulating the tumor microenvironment.
VELP™ AAV Vector Evolution Platform
A gene therapy platform that evolves adeno-associated virus (AAV) vectors with high-quality viral libraries for targeted gene delivery to specific tissues or cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B
obfuscation
Series B - CureGenetics Logo
Series B - CureGenetics
1
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1 Board Members and Advisors 1 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•Sep 15, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 5, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

380
26.67%
 in past month

Interest Signals

TopicSurge Score
Burglar Alarms Logo
Burglar Alarms
72

Active Website Tech Count

3CureGenetics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, SPF, and  Baidu Maps.
Sub-Organizations
Frequently Asked Questions

Where is CureGenetics's headquarters? CureGenetics is located in Suzhou, Jiangsu, China.Who invested in CureGenetics? CureGenetics has 7 investors including Qiming Venture Partners and  Blue Ocean Capital Group.When was the last funding round for CureGenetics? CureGenetics closed its last funding round on
obfuscation
from a Series B round.Who are CureGenetics's competitors? Alternatives and possible competitors to CureGenetics may include Dyno Therapeutics, Asklepios BioPharmaceutical, and  Caribou Biosciences.How much funding has CureGenetics raised to date? CureGenetics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|